I don't think it's great for us. One aspect is the approval which bodes well for us for our own pathway but having Mindmed doing relatively the same therapy takes the unique factor away. If I was buying in, this pathway wouldn't be where I would be expecting my investment return. It may have some positive influence on our SP short term as people may see our GAD treatment being derisked. It will all depend on our results vs theirs. If they get to the end first then that softens our impact. Please someone have the opposite view........
- Forums
- ASX - By Stock
- IHL
- Industry news
Industry news, page-509
-
- There are more pages in this discussion • 390 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online